Arsenal Bio

Description

Arsenal Bio develops in vivo T cell therapies and reprogrammed CAR T approaches for chronic diseases, including cancer and autoimmunity, with focus on solid tumor challenges.

Arsenal Bio is located in the Silicon Valley ecosystem.

Related

• Vivere OncotherapiesVivere Oncotherapies develops engineered cancer therapies that activate patients’ immune systems to find and kill tumor cells, focusing on…
• Umoja BiopharmaDevelops in vivo CAR T cell therapies and lentiviral manufacturing to support on-demand treatment, aiming to reduce ex vivo manufacturing…
• Kyverna Therapeutics ($KYTX)Kyverna Therapeutics develops CAR T-cell therapies for patients living with autoimmune diseases, with a late-stage clinical immunology…
• Iovance Biotherapeutics ($IOVA)Iovance Biotherapeutics develops T-cell-based immunotherapy platforms, including tumor-infiltrating lymphocyte therapy, for cancer…
• Kyverna Therapeutics (San Diego)Kyverna Therapeutics (San Diego) develops cell therapies for patients with autoimmune diseases, centered on a CAR T-cell therapy pipeline…
• Metagenomi ($MGX)Metagenomi develops in vivo genome editing medicines, using tools discovered from environmental genetic material to correct genetic…
• Precision BioSciences ($DTIL)Precision BioSciences develops genome-editing therapies using its ARCUS platform to treat diseases; it runs clinical programs delivering…
• march.biosciencesDevelops clinical-stage CAR-T cell therapies, including MB-105, aimed at difficult hematological cancers, with a focus on relapsed or…
• Crinetics PharmaceuticalsCrinetics Pharmaceuticals discovers, develops, and commercializes therapies for endocrine diseases and endocrine-related tumors, serving…